XML 55 R44.htm IDEA: XBRL DOCUMENT v3.19.2
Subsidiary Bankruptcy and Deconsolidation (Details) - USD ($)
3 Months Ended 6 Months Ended
Apr. 26, 2019
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Jul. 02, 2019
Feb. 08, 2019
Business Acquisition, Contingent Consideration [Line Items]              
Gain (loss) on deconsolidation of subsidiary   $ (167,000) $ 0 $ (2,840,000) $ 0    
DIP Credit Agreement | Debtor in Possession Credit and Security Facility              
Business Acquisition, Contingent Consideration [Line Items]              
Gain (loss) on deconsolidation of subsidiary   (407,000)          
Payments for debtor in possession financing   407,000          
Speciality Pharama              
Business Acquisition, Contingent Consideration [Line Items]              
Aggregate cash proceeds of intangible assets and remaining inventory $ 250,000            
Speciality Pharama | Internal Revenue Service (IRS) | Subsequent Event              
Business Acquisition, Contingent Consideration [Line Items]              
Bankruptcy claims, amount of filed claims likely to be denied           $ 50,695,000  
Speciality Pharama | DIP Credit Agreement | Debtor in Possession Credit and Security Facility              
Business Acquisition, Contingent Consideration [Line Items]              
DIP financing, amount arranged             $ 2,700,000
Specialty Pharma              
Business Acquisition, Contingent Consideration [Line Items]              
Equity method investments, fair value   $ 0   $ 0